tiletamine hydrochloride has been researched along with Cancer of Pancreas in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bugde, P; Hawkins, BC; Li, Y; Paxton, JW; Revalde, JL; Rosengren, RJ; Wijeratne, TS | 1 |
| Ito, A; Kawai, T; Ogasawara, A; Saisho, Y; Simizu, S; Takei, I; Umezawa, K | 1 |
| Baba, M; Fujiyoshi, M; Haga, S; Kamiyama, T; Mino, K; Nakanishi, K; Niwa, H; Ohmiya, Y; Ozaki, M; Sato, M; Taketomi, A; Todo, S; Umezawa, K; Yokoo, H | 1 |
| Aiura, K; Itano, O; Kitagawa, Y; Matsuda, S; Suzuki, K; Takeuchi, O; Umezawa, K | 1 |
| Ichikawa, E; Kamiya, D; Kato, K; Uchihata, Y; Umezawa, K | 1 |
| Matsumoto, G; Misumi, K; Muta, M; Okamoto, A; Suzuki, T; Toi, M; Tsuruta, K; Umezawa, K | 1 |
| Hirose, H; Horimai, C; Itoh, H; Miyashita, K; Saisho, Y; Takei, I; Umezawa, K | 1 |
7 other study(ies) available for tiletamine hydrochloride and Cancer of Pancreas
| Article | Year |
|---|---|
Curcumin and its cyclohexanone analogue inhibited human Equilibrative nucleoside transporter 1 (ENT1) in pancreatic cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Curcumin; Cyclohexanones; Deoxycytidine; Drug Interactions; Drug Resistance, Neoplasm; Equilibrative Nucleoside Transporter 1; Gemcitabine; Humans; Pancreatic Neoplasms; Uridine | 2017 |
Inhibition of NO-induced β-cell death by novel NF-κB inhibitor (-)-DHMEQ via activation of Nrf2-ARE pathway.
Topics: Animals; Antioxidant Response Elements; Apoptosis; Benzamides; Cyclohexanones; Gene Knockdown Techniques; Insulin-Secreting Cells; Insulinoma; Mice; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Pancreatic Neoplasms; Signal Transduction; Tumor Cells, Cultured | 2013 |
Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, (-)-DHMEQ.
Topics: Animals; Anoikis; Apoptosis Regulatory Proteins; Benzamides; Cell Line, Tumor; Cyclohexanones; Disease Models, Animal; Gene Expression; Genes, Reporter; Humans; Mice; Molecular Imaging; NF-kappa B; Pancreatic Neoplasms; Peritoneal Neoplasms; Protein Binding; Transcription Factor RelA; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Cell Movement; Cell Proliferation; Cyclohexanones; Deoxycytidine; Disease Models, Animal; Fluorescent Antibody Technique; Gemcitabine; Humans; Immunoenzyme Techniques; Interleukin-8; Liver Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2013 |
Reversal of anticancer drug resistance by COTC based on intracellular glutathione and glyoxalase I.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclohexanones; Drug Resistance, Neoplasm; Glutathione; Humans; Lactoylglutathione Lyase; Pancreatic Neoplasms; Structure-Activity Relationship | 2005 |
Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-kappaB inhibitor.
Topics: Apoptosis; Benzamides; Caspase 3; Caspases; Cell Survival; Cyclohexanones; Drug Interactions; Humans; Kinetics; Mitochondria; Pancreatic Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Up-Regulation | 2005 |
Effects of DHMEQ, a novel nuclear factor-kappab inhibitor, on beta cell dysfunction in INS-1 cells.
Topics: Animals; Benzamides; Cell Line, Tumor; Cell Survival; Cyclohexanones; Dose-Response Relationship, Drug; Glucose; Insulin; Insulin-Secreting Cells; Insulinoma; NF-kappa B; Pancreatic Neoplasms; Rats; Tumor Necrosis Factor-alpha | 2008 |